How clinical trials work — and how to know if you qualify

Short answer: A clinical trial is a study testing a treatment that isn't standard care yet. Eligibility comes down to a written list called inclusion and exclusion criteria — usually your exact cancer type and subtype, your stage, which treatments you've already had, your organ function on recent labs, and your performance status. You almost never pay for the investigational drug. The fastest way to find out if you qualify is to ask your oncologist "are there trials open for my exact subtype here or nearby?" and to search clinicaltrials.gov by condition plus your state.

Two myths keep people out of trials. The first is that a trial is a last resort. The second is that you might get a sugar pill instead of treatment. Neither is generally true in cancer care: trials run at every stage including first-line, and placebo-only arms are rare — the standard comparison is the current best treatment, sometimes plus the new drug.

The phases, in plain terms

• Phase 1 — Is it safe, and at what dose? Small groups. Historically a late-line option, but in modern targeted and immunotherapy trials, phase 1 can be where the most promising drugs first appear.
• Phase 2 — Does it actually work against this cancer? Larger groups, efficacy-focused.
• Phase 3 — Is it better than the current standard? Large, often randomized. This is the phase that changes practice.
• Phase 4 — Long-term safety after approval.

What "randomized" really means

In a randomized trial, a computer assigns you to a group. In cancer trials the usual design is standard treatment versus standard treatment plus the new drug, or standard versus a new alternative. You are not left untreated. If a placebo is used at all, it's typically added on top of real treatment, and the consent form must tell you plainly. Ask directly: "Could I receive no active treatment in any arm of this study?"

How eligibility actually works

Every trial has a written list of inclusion and exclusion criteria. The common ones:

• Exact diagnosis and subtype — often down to a specific mutation or marker (EGFR, HER2, BRAF, MSI-high, FLT3, del(17p))
• Stage and prior treatment — many trials specify "untreated" or "after exactly one prior line"
• Recent lab values — kidney, liver, and blood counts within defined ranges
• Performance status — a 0–5 scale (ECOG) describing how much of the day you're up and active; most trials want 0–1, some allow 2
• Other conditions — active infections, other cancers, or certain heart conditions can exclude
• Washout period — a required gap since your last treatment

This is why the answer is so specific to you, and why generic "do I qualify" searching is frustrating. One missing molecular test can be the whole difference — which is a good reason to ask whether your tumor has had comprehensive genomic profiling.

How to find trials

1. Ask your oncologist first. Say: "Are there clinical trials open for my exact subtype and stage, here or at a center near us?" If they say no, ask whether a referral to an NCI-designated center for trial screening makes sense.
2. clinicaltrials.gov — search by condition and location. Filter to "recruiting."
3. NCI's trial search at cancer.gov — the same registry, organized for patients.
4. Disease-specific nonprofits — the Leukemia & Lymphoma Society, LUNGevity, and similar groups run free trial-matching navigator services staffed by nurses.
5. The center's research office — every academic cancer center has trial coordinators you can call directly.

What it costs

Generally: the study covers the investigational drug and any tests required only by the study. Your insurance is billed for routine care you'd receive anyway — standard scans, standard drugs, office visits. Federal law requires most plans to cover routine costs of qualifying trials, and Medicare does. Travel and lodging may or may not be reimbursed; ask, because some trials and nonprofits have stipends.

Ask the coordinator flatly: "What will I be billed for, and what does the study pay?"

Questions to ask before enrolling

• What is this trial testing, and what's the alternative if I don't join?
• What phase is it, and what's already known about this drug's safety?
• What are the arms, and what's my chance of each?
• What extra visits, scans, or biopsies does the trial require beyond normal care?
• What are the known side effects so far?
• What happens if it doesn't work, or if I want to stop? (You can withdraw at any time.)
• If it does work, do I keep getting the drug after the study ends?
• Who do I call with problems, day and night?
• What is billed to insurance, and is travel covered?

The realistic picture

Only a small fraction of adult cancer patients enroll in trials, and the most common reason isn't refusal — it's that nobody brought it up, or the nearest trial was two hours away. Bringing the question yourself is often what makes it happen.

If you want help translating a specific trial's eligibility page into whether it plausibly fits your situation, you can paste it into Cura along with your pathology report — you'll get a plain-language read and the questions to ask the trial coordinator. Cura won't tell you whether you qualify; only the study team can. Nothing you upload is saved.

Related reading: how to get a second opinion, what cancer scans and tests cost, and what to ask after a cancer diagnosis.